1. Home
  2. LSAK vs KRRO Comparison

LSAK vs KRRO Comparison

Compare LSAK & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • KRRO
  • Stock Information
  • Founded
  • LSAK 1997
  • KRRO 2014
  • Country
  • LSAK South Africa
  • KRRO United States
  • Employees
  • LSAK N/A
  • KRRO N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • KRRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSAK Finance
  • KRRO Health Care
  • Exchange
  • LSAK Nasdaq
  • KRRO Nasdaq
  • Market Cap
  • LSAK 384.3M
  • KRRO 358.3M
  • IPO Year
  • LSAK N/A
  • KRRO 2019
  • Fundamental
  • Price
  • LSAK $4.29
  • KRRO $48.57
  • Analyst Decision
  • LSAK
  • KRRO Strong Buy
  • Analyst Count
  • LSAK 0
  • KRRO 7
  • Target Price
  • LSAK N/A
  • KRRO $96.71
  • AVG Volume (30 Days)
  • LSAK 70.6K
  • KRRO 233.8K
  • Earning Date
  • LSAK 11-05-2025
  • KRRO 11-11-2025
  • Dividend Yield
  • LSAK N/A
  • KRRO N/A
  • EPS Growth
  • LSAK N/A
  • KRRO N/A
  • EPS
  • LSAK N/A
  • KRRO N/A
  • Revenue
  • LSAK $659,702,000.00
  • KRRO $6,281,000.00
  • Revenue This Year
  • LSAK N/A
  • KRRO $116.91
  • Revenue Next Year
  • LSAK N/A
  • KRRO N/A
  • P/E Ratio
  • LSAK N/A
  • KRRO N/A
  • Revenue Growth
  • LSAK 16.92
  • KRRO N/A
  • 52 Week Low
  • LSAK $3.39
  • KRRO $10.29
  • 52 Week High
  • LSAK $5.60
  • KRRO $98.00
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 46.75
  • KRRO 72.86
  • Support Level
  • LSAK $4.00
  • KRRO $43.41
  • Resistance Level
  • LSAK $4.29
  • KRRO $49.01
  • Average True Range (ATR)
  • LSAK 0.18
  • KRRO 4.42
  • MACD
  • LSAK 0.02
  • KRRO 0.46
  • Stochastic Oscillator
  • LSAK 53.23
  • KRRO 93.46

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: